Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypoglycemia | D007003 | — | E16.2 | — | 3 | — | — | — | 3 |
Congenital hyperinsulinism | D044903 | — | — | — | 1 | — | — | — | 1 |
Nesidioblastosis | D046768 | EFO_0007318 | E16.9 | — | 1 | — | — | — | 1 |
Drug common name | Avexitide |
INN | avexitide |
Description | Avexitide is a protein pharmaceutical. It is currently being investigated in clinical studies. It is known to target glucagon-like peptide 1 receptor. |
Classification | Protein |
Drug class | peptides |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4297949 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 5313W10MYT (ChemIDplus, GSRS) |